Table 2.
Summary of the guideline-adherence distribution
| Total enterprises | Local governments (as reference) | ||||
|---|---|---|---|---|---|
| (N = 432) | (N = 1737) | ||||
| N | % | N | % | p value | |
| Colorectal cancer screening | < 0.01 | ||||
| Underscreening | 71 | 16.4% | 363 | 20.9% | |
| Guideline-adherent screening | 55 | 12.7% | 1083 | 62.3% | |
| Overscreening | 306 | 70.8% | 291 | 16.8% | |
| Breast cancer screening | < 0.01 | ||||
| Underscreening | 129 | 29.9% | 664 | 38.2% | |
| Guideline-adherent screening | 13 | 3.0% | 202 | 11.6% | |
| Overscreening | 290 | 67.1% | 871 | 50.1% | |
| Cervical cancer screening | < 0.01 | ||||
| Underscreening | 262 | 60.6% | 596 | 34.3% | |
| Guideline-adherent screening | 38 | 8.8% | 556 | 32.0% | |
| Overscreening | 132 | 30.6% | 585 | 33.7% | |
The category of "Underscreening" encompasses enterprises classified as "No screening," "Unanswered," and "Underscreening"